GXJ
IONS icon

Global X Japan’s Ionis Pharmaceuticals IONS Stock Holding History

Global X Japan’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.1K Buy
279
+151
+118% +$11.4K ﹤0.01% 286
2026
Q1 		$9.61K Sell
128
-43
-25% -$3.39K ﹤0.01% 342
2025
Q4 		$13.5K Sell
171
-150
-47% -$11.3K ﹤0.01% 268
2025
Q3 		$21K Buy
321
+62
+24% +$3.03K ﹤0.01% 235
2025
Q2 		$10.2K Buy
+259
New +$8.48K ﹤0.01% 270
2025
Q1 		– Sell
-297
Closed -$10.4K – 310
2024
Q4 		$10.4K Buy
297
+62
+26% +$2.32K ﹤0.01% 252
2024
Q3 		$9.41K Sell
235
-27
-10% -$1.26K ﹤0.01% 277
2024
Q2 		$12.5K Sell
262
-407
-61% -$16.7K ﹤0.01% 241
2024
Q1 		$29K Sell
669
-47
-7% -$2.24K 0.01% 171
2023
Q4 		$36.2K Buy
+716
New +$34.3K 0.02% 144

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Global X Japan's IONS Position: Q2 2026 in Review

Global X Japan increased its Ionis Pharmaceuticals (IONS) stake by 118% in Q2 2026, buying an estimated $11.4K and bringing the position to 279 shares worth $22.1K. The position accounts for ﹤0.01% of the portfolio, ranked #286.

Global X Japan first reported a position in IONS in Q4 2023 and has held it in 10 quarters since. The position peaked at $36.2K in Q4 2023. 515 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Global X Japan held 279 shares of Ionis Pharmaceuticals worth $22.1K as of Q2 2026.
  • Global X Japan bought 151 Ionis Pharmaceuticals shares in Q2 2026, an estimated $11.4K.
  • Ionis Pharmaceuticals made up ﹤0.01% of Global X Japan's portfolio in Q2 2026, its #286 holding.
  • Global X Japan first reported a position in Ionis Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
  • Global X Japan's Ionis Pharmaceuticals position peaked at $36.2K in Q4 2023.
  • 515 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Global X Japan's 13F filing for Q2 2026, filed 14 Jul 2026.